An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study

被引:9
作者
Gao, Fan [1 ]
Bian, Lian-lian [1 ]
Mao, Qun-ying [1 ]
Chen, Pan [1 ]
Yao, Xin [1 ]
Li, Jing-xin [2 ]
Zhu, Feng-cai [2 ]
Liang, Zheng-lun [1 ]
机构
[1] Natl Inst Food & Drug Control, 2 Tiantan Xili, Beijing 100050, Peoples R China
[2] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China
关键词
Coxsackievirus B3; Prospective cohort study; Hand; foot and mouth disease; MOUTH-DISEASE PATIENTS; PROTECTS MICE; VACCINE; MYOCARDITIS; TRIAL;
D O I
10.1007/s00705-016-2842-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To investigate the epidemiological data on coxsackievirus B3 (CVB3) infection and its incidence in infants and children, a prospective cohort study was carried out from 2012 to 2014 in Jiangsu Province, China. According to the results of seropositive rates and NTAb titers of CVB3, an epidemic of CVB3 infection was found, and a dynamic change in CVB3 neutralizing antibody was also observed. One case was recorded with CVB3-associated hand, foot and mouth disease (HFMD), and the isolates belonged to the CVB3 D2 subtype. Our data help us to better understand the epidemic characteristics of CVB3 infection in infants and children.
引用
收藏
页码:1945 / 1947
页数:3
相关论文
共 14 条
[1]   A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection [J].
Dan, M ;
Chantler, JK .
JOURNAL OF VIROLOGY, 2005, 79 (14) :9285-9295
[2]   Specific primer amplification of the VP1 region directed by 5′ UTR sequence analysis: Enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients [J].
Ge, Shengxiang ;
Yan, Qiang ;
He, Shuizhen ;
Zhuang, Sijie ;
Niu, Jianjun ;
Xia, Ningshao .
JOURNAL OF VIROLOGICAL METHODS, 2013, 193 (02) :463-469
[3]  
Henke Andreas, 2003, Expert Rev Vaccines, V2, P805, DOI 10.1586/14760584.2.6.805
[4]   Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines [J].
Kim, Dae-Sun ;
Nam, Jae-Hwan .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (02) :179-190
[5]   Clinical Features of Coxsackievirus A4, B3 and B4 Infections in Children [J].
Lee, Chia-Jie ;
Huang, Yhu-Chering ;
Yang, Shuan ;
Tsao, Kuo-Chien ;
Chen, Chih-Jung ;
Hsieh, Yu-Chia ;
Chiu, Cheng-Hsun ;
Lin, Tzou-Yien .
PLOS ONE, 2014, 9 (02)
[6]   Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines [J].
Liang, Zhenglun ;
Mao, Qunying ;
Gao, Qiang ;
Li, Xiuling ;
Dong, Chenghong ;
Yu, Xiang ;
Yao, Xin ;
Li, Fengxiang ;
Yin, Weidong ;
Li, Qihan ;
Shen, Xinliang ;
Wang, Junzhi .
VACCINE, 2011, 29 (52) :9668-9674
[7]   Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis [J].
Park, Jung-Hyun ;
Kim, Dae-Sun ;
Cho, Young-Joo ;
Kim, Yeon-Jung ;
Jeong, Soo-Young ;
Lee, Seung-Min ;
Cho, Seong-Joo ;
Yun, Cheol-Won ;
Jo, Inho ;
Nam, Jae-Hwan .
VACCINE, 2009, 27 (13) :1974-1983
[8]   Seroprevalence of Coxsackievirus B3 in Yantai, China [J].
Tao, Zexin ;
Li, Bo ;
Xu, Aiqiang ;
Liu, Yao ;
Song, Lizhi ;
Wang, Suting ;
Xiong, Ping ;
Lin, Xiaojuan ;
Song, Yanyan .
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (06) :537-538
[9]   Coxsackievirus B3, Shandong Province, China, 1990-2010 [J].
Tao, Zexin ;
Song, Yanyan ;
Li, Yan ;
Liu, Yao ;
Jiang, Ping ;
Lin, Xiaojuan ;
Liu, Guifang ;
Song, Lizhi ;
Wang, Haiyan ;
Xu, Aiqiang .
EMERGING INFECTIOUS DISEASES, 2012, 18 (11) :1865-1867
[10]   Prevalence of Multiple Enteroviruses Associated with Hand, Foot, and Mouth Disease in Shijiazhuang City, Hebei Province, China: Outbreaks of Coxsackieviruses A10 and B3 [J].
Tian, Huifang ;
Zhang, Yong ;
Sun, Qiang ;
Zhu, Shuangli ;
Li, Xiujuan ;
Pan, Zhuo ;
Xu, Wenbo ;
Xu, Baohong .
PLOS ONE, 2014, 9 (01)